ライフサイエンスコーパス: Klebsiella pneumoniae

1 erococcus faecium, and beta-lactam-resistant Klebsiella pneumoniae).

2 carbapenemase OXA-48, in lysate samples from Klebsiella pneumoniae.

3 cus faecium (VRE), and beta-lactam-resistant Klebsiella pneumoniae.

4 ssues of infected mice by the human pathogen Klebsiella pneumoniae.

5 are also active against MDR E. coli and MDR Klebsiella pneumoniae.

6 o lung infection by the major human pathogen Klebsiella pneumoniae.

7 richia coli O157:H7, and multidrug resistant Klebsiella pneumoniae.

8 eptible to infection by Escherichia coli and Klebsiella pneumoniae.

9 a variety of bacterial pathogens, including Klebsiella pneumoniae.

10 the rapid dissemination of a single clone of Klebsiella pneumoniae.

11 h diverse KPC producers not limited to ST258 Klebsiella pneumoniae.

12 ntibiotic-resistant metallo-beta-lactamase 1 Klebsiella pneumoniae.

13 in pathogenesis during bacteremia caused by Klebsiella pneumoniae.

14 clearance after intratracheal challenge with Klebsiella pneumoniae.

15 ed in the lung in response to infection with Klebsiella pneumoniae.

16 e development of multicellular aggregates of Klebsiella pneumoniae.

17 esistance enzyme that is normally present in Klebsiella pneumoniae.

18 ve Streptococcus pneumoniae or Gram-negative Klebsiella pneumoniae.

19 novel pathway for purine catabolism found in Klebsiella pneumoniae.

20 oss-protection against multiple serotypes of Klebsiella pneumoniae.

21 ative pathogens, Acinetobacter baumannii and Klebsiella pneumoniae.

22 tance mechanism encountered in an isolate of Klebsiella pneumoniae.

23 ng challenge with the Gram-negative pathogen Klebsiella pneumoniae.

24 episodes of cryptogenic liver abscess due to Klebsiella pneumoniae.

25 rol of the Gram-negative pulmonary pathogen, Klebsiella pneumoniae.

26 human pathogens Streptococcus pneumoniae and Klebsiella pneumoniae.

27 ococcus faecium, Acinetobacter baumannii and Klebsiella pneumoniae.

28 verlapping AR genes, and are correlated with Klebsiella pneumoniae.

29 Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae.

30 , extended-spectrum beta-lactamase-producing Klebsiella pneumoniae [10], carbapenem-resistant Acineto

31 d intention-to-treat population (n=355) were Klebsiella pneumoniae (37%) and Pseudomonas aeruginosa (

32 The most frequent organism was Klebsiella pneumoniae (375 [86%] of 437; 291 [85%] of 34

33 odes due to Acinetobacter baumannii (46.4%), Klebsiella pneumoniae (46.4%), and Pseudomonas aeruginos

34 coli (28%), Burkholderia pseudomallei (11%), Klebsiella pneumoniae (9%), and Staphylococcus aureus (6

35 thod was as follows; Escherichia coli, 100%; Klebsiella pneumoniae, 92.9%; Klebsiella oxytoca, 95.5%;

36 Klebsiella pneumoniae, a bacterial pathogen that has acq

37 Klebsiella pneumoniae, a chief cause of nosocomial pneum

38 ce were tail vein-injected with 10(8) CFU of Klebsiella pneumoniae, a common cause of EBE in diabetic

39 I agents, and multidrug-resistant strains of Klebsiella pneumoniae, a leading HAI agent, have caused

40 as historically largely been associated with Klebsiella pneumoniae, a predominant plasmid (pKpQIL), a

41 CutC GRE and the activating enzyme CutD from Klebsiella pneumoniae, a representative of the human mic

42 anavalin, Pichia pastoris lysyl oxidase, and Klebsiella pneumoniae acetolactate synthase.

43 y in intensive care units, of multiresistant Klebsiella pneumoniae, Acinetobacter baumanni, and Pseud

44 beta-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

45 In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropene

46 colonization caused by carbapenem-resistant Klebsiella pneumoniae among profoundly immunocompromised

47 nterobacteriaceae isolates, 125 (94.7%) were Klebsiella pneumoniae and 74 harbored K. pneumoniae carb

48 ptococus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli in Conjunctiv

49 on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European h

50 We compared detection of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillan

51 terferes with their cognate function against Klebsiella pneumoniae and Escherichia coli; vi) MAIT cel

52 ntratracheal KC chemokine, and intratracheal Klebsiella pneumoniae and impairs pulmonary host defense

53 tures of the full-length MtfA apoenzyme from Klebsiella pneumoniae and its complex with zinc (holoenz

54 (-/-) mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis.

55 sortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae) has

56 obacteriaceae, including multidrug-resistant Klebsiella pneumoniae and pathogenic Escherichia coli, r

57 ainst Enterococcus faecium, platinum against Klebsiella pneumoniae and platinum and silver against Ac

58 Klebsiella pneumoniae and Pseudomonas aeruginosa are mic

59 d extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Salmonella typhimurium.

60 Escherichia coli and Klebsiella pneumoniae and the CEZ are used as the sample

61 e species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli .

62 . aureus], 2 Stenotrophomonas maltophilia, 1 Klebsiella pneumoniae) and resulted in antimicrobial cha

63 , Clostridium perfringens, Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis.

64 resistant Enterococcus, carbapenem-resistant Klebsiella pneumoniae, and Escherichia coli infection in

65 riggered by LPS from Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli Sixteen cyto

66 bacterium tuberculosis, Salmonella enterica, Klebsiella pneumoniae, and Escherichia coli We compare p

67 esistant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus spp.

68 , Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa repres

69 of Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa We the

70 Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were t

71 cies-Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa-report

72 , Enterococcus faecalis, Klebsiella oxytoca, Klebsiella pneumoniae, and Staphylococcus aureus at age

73 ucosal challenge with the pulmonary pathogen Klebsiella pneumoniae, and substantially reduced epithel

74 Nosocomial infections with Klebsiella pneumoniae are a frequent cause of Gram-negat

75 , Micrococcus luteus, Bacillus subtilis, and Klebsiella pneumoniae at a minimal inhibitory concentrat

76 was hospitalized with septic shock caused by Klebsiella pneumoniae bacteremia.

77 Upon Klebsiella pneumoniae bacterial infection, CD4(+) and ga

78 ein A (TTPA) is a structural tail protein of Klebsiella pneumoniae bacteriophage KP32, and is respons

79 oduction of antibiotics, multidrug-resistant Klebsiella pneumoniae became an escalating threat.

80 oteins from E. coli, Salmonella enterica and Klebsiella pneumoniae bind c-di-GMP via the domain of un

81 t SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithe

82 e solution structure of the BLUF domain from Klebsiella pneumoniae BlrP1, a light-activated c-di-guan

83 The structure of UGM from Klebsiella pneumoniae bound to the substrate analog UDP-

84 portant carbapenem-resistant human pathogen, Klebsiella pneumoniae, by B. bacteriovorus in human seru

85 CPOs carrying the Klebsiella pneumoniae carbapenemase (bla KPC ) gene have

86 nded-spectrum beta-lactamase (bla(ESBL)) and Klebsiella pneumoniae carbapenemase (bla(KPC)) genes.

87 duplex, real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase (blaKPC) and New Del

88 In the United States, CRE producing the Klebsiella pneumoniae carbapenemase (KPC) are increasing

89 detection of ertapenem (ETP) resistance and Klebsiella pneumoniae carbapenemase (KPC) in 47 Klebsiel

90 In the United States, the production of the Klebsiella pneumoniae carbapenemase (KPC) is an importan

91 Klebsiella pneumoniae carbapenemase (KPC) production in

92 ogy labs to perform confirmatory testing for Klebsiella pneumoniae carbapenemase (KPC) production or

93 The Klebsiella pneumoniae carbapenemase (KPC) was detected i

94 Imipenemase (IMP), Klebsiella pneumoniae carbapenemase (KPC), and Verona in

95 n of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhib

96 loped targeting the bla(KPC) responsible for Klebsiella pneumoniae carbapenemase (KPC)-mediated carba

97 In the United States, Klebsiella pneumoniae carbapenemase (KPC)-producing Ente

98 esent the first reported infection caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Ente

99 Two clinical strains of Klebsiella pneumoniae carbapenemase (KPC)-producing K. p

100 Klebsiella pneumoniae carbapenemase (KPC)-producing K. p

101 rbapenemase production in a collection of 14 Klebsiella pneumoniae carbapenemase (KPC)-producing non-

102 inhibitor was evaluated for the detection of Klebsiella pneumoniae carbapenemase (KPC)-type beta-lact

103 or detection of Enterobacteriaceae producing Klebsiella pneumoniae carbapenemase (KPC)-type carbapene

104 oncerning is the widespread dissemination of Klebsiella pneumoniae carbapenemase (KPC).

105 tam antibiotics due to the production of the Klebsiella pneumoniae carbapenemase (KPC-2) class A beta

106 Klebsiella pneumoniae carbapenemase-producing Enterobact

107 Vancomycin-resistant enterococci and Klebsiella pneumoniae carbapenemase-producing K. pneumon

108 in was effective for treating 24 of 26 (92%) Klebsiella pneumoniae carbapenemase-producing K. pneumon

109 the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumon

110 e performed on isolates to identify specific Klebsiella pneumoniae carbapenemases (KPC) and additiona

111 bapenem resistance mediated by plasmid-borne Klebsiella pneumoniae carbapenemases (KPC) is an emergin

112 e, in contrast to metallo-beta-lactamases or Klebsiella pneumoniae carbapenemases (KPC), no specific

113 eloped a novel real-time PCR assay to detect Klebsiella pneumoniae carbapenemases (KPCs) and used thi

114 Klebsiella pneumoniae carbapenemases (KPCs) are consider

115 Detection of Klebsiella pneumoniae carbapenemases (KPCs) can be nonsp

116 Klebsiella pneumoniae carbapenemases (KPCs) have recentl

117 Klebsiella pneumoniae carbapenemases (KPCs) were first i

118 Klebsiella pneumoniae carbapenemases (KPCs) were origina

119 fication of variants of carbapenem resistant Klebsiella pneumoniae carbapenemases and monitored by en

120 em-resistant Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemases.

121 Klebsiella pneumoniae carriage frequencies were estimate

122 Klebsiella pneumoniae causes a wide range of infections,

123 Klebsiella pneumoniae causes extensive lung damage.

124 Klebsiella pneumoniae causes serious, life-threatening i

125 Klebsiella pneumoniae causes severe lung and bloodstream

126 Klebsiella pneumoniae causing community-acquired pyogeni

127 teriaceae, primarily involving KPC-producing Klebsiella pneumoniae clonal complex CC258.

128 fecal material, resulting in eradication of Klebsiella pneumoniae compared with nonresponders.

129 ial activity against E. coli, Salmonella and Klebsiella pneumoniae, comparing to the supercritical ex

130 am-negative bacteria on clinical isolates of Klebsiella pneumoniae, containing highly-resistant antim

131 Infections caused by carpabenem-resistant Klebsiella pneumoniae (CR-Kp) are especially problematic

132 rgently needed to treat carbapenem-resistant Klebsiella pneumoniae (CR-Kp)-mediated infection, which

133 sortium on Resistance against Carbapenems in Klebsiella pneumoniae (CRACKLE) was constructed of patie

134 The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a major public h

135 k of OXA-232-expressing carbapenem-resistant Klebsiella pneumoniae (CRKP) transmitted to 16 patients

136 e growing importance of carbapenem-resistant Klebsiella pneumoniae (CRKP), the clonal relationships b

137 or infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKp).

138 nding global distribution of multi-resistant Klebsiella pneumoniae demands faster antimicrobial susce

139 Here we show that mice infected with Klebsiella pneumoniae develop lung injury with accumulat

140 The most common CRE species were Klebsiella pneumoniae, Enterobacter aerogenes, and Esche

141 ultidrug-resistant bacterial species such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotropho

142 hia coli (ESBL-Ec; n = 72) or ESBL-producing Klebsiella pneumoniae (ESBL-Kp; n = 10) and their hospit

143 0.7%, respectively, caused by ESBL-producing Klebsiella pneumoniae, Escherichia coli, Klebsiella oxyt

144 scovery of a new enzyme, first identified in Klebsiella pneumoniae from a patient from New Delhi and

145 se shorter probes allowed differentiation of Klebsiella pneumoniae from Proteus mirabilis 16S rRNA ta

146 tor that binds to the upstream region of the Klebsiella pneumoniae gdhA promoter and stimulates gdhA

147 riable regions V3 and V6 were amplified from Klebsiella pneumoniae genomic DNA with blood in situ.

148 teria (Pseudomonas aeruginosa, 16-32 mug/mL, Klebsiella pneumoniae > 32 mug/mL).

149 Klebsiella pneumoniae harboring blaKPC (KPC-Kpn) is ende

150 nst clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to su

151 Klebsiella pneumoniae has a reputation for causing a wid

152 activity against Acinetobacter baumannii and Klebsiella pneumoniae; however, analogue 9 and 16 at 4 m

153 spiked with approximately 1,500 CFU bla(KPC) Klebsiella pneumoniae; however, the detection rate dropp

154 Here we present evidence that Klebsiella pneumoniae HpxJ is an aminotransferase that p

155 minant siderophore produced by hypervirulent Klebsiella pneumoniae (hvKP) and was previously shown to

156 New hypervirulent variants of Klebsiella pneumoniae (hvKP) are emerging globally, most

157 Hypervirulent Klebsiella pneumoniae (hvKP) is an emerging pathotype th

158 Hypervirulent (hypermucoviscous) Klebsiella pneumoniae (hvKP) strains are an emerging var

159 ollowing intranasal or i.p. inoculation with Klebsiella pneumoniae, IL-6 (-/-) mice are less likely t

160 lly track a clonal outbreak of blaKPC-pKpQIL-Klebsiella pneumoniae in a proof-of-principle study.

161 ogues with in vivo efficacy against MRSA and Klebsiella pneumoniae in animal models of infection.

162 a17 cell numbers in vivo, we used a model of Klebsiella pneumoniae in mice deficient in STAT6.

163 We report an outbreak of NDM-producing Klebsiella pneumoniae in patients with no prior travel h

164 the major uropathogens Proteus mirabilis and Klebsiella pneumoniae, in addition to UPEC, in humans.

165 lipopolysaccharide transporter LptB2FG from Klebsiella pneumoniae, in which both LptF and LptG are c

166 so show that expression of Gam in E. coli or Klebsiella pneumoniae increases sensitivity to fluoroqui

167 d in vivo during pneumoseptic infection with Klebsiella pneumoniae, indicating its regulatory role in

168 or in combination with Escherichia coli- or Klebsiella pneumoniae-induced pneumonia.

169 pocalin 2 is rapidly and robustly induced by Klebsiella pneumoniae infection and is TLR4 dependent.

170 reported that host defense against pulmonary Klebsiella pneumoniae infection requires IL-22, which wa

171 zone to induce Paneth cell loss, followed by Klebsiella pneumoniae infection to induce intestinal inj

172 uction in the lungs of CXCL1(-/-) mice after Klebsiella pneumoniae infection.

173 mediated inflammation in the lungs following Klebsiella pneumoniae infection.

174 Carbapenem-resistant Klebsiella pneumoniae infections are increasingly preval

175 The increasing incidence of Klebsiella pneumoniae infections refractory to treatment

176 Klebsiella pneumoniae is a common cause of endogenous ba

177 Klebsiella pneumoniae is a common colonizer of the gastr

178 Klebsiella pneumoniae is a common respiratory pathogen,

179 Klebsiella pneumoniae is a leading cause of both communi

180 trogen assimilation control protein (NAC) of Klebsiella pneumoniae is a LysR-type transcriptional reg

181 Klebsiella pneumoniae is a pathogen of increasing concer

182 ogen assimilation control protein (NAC) from Klebsiella pneumoniae is a typical LysR-type transcripti

183 Klebsiella pneumoniae is able to utilize many nitrogen s

184 Klebsiella pneumoniae is an etiologic agent of community

185 Klebsiella pneumoniae is an important cause of urinary t

186 Klebsiella pneumoniae is an opportunistic pathogen and l

187 Klebsiella pneumoniae is an opportunistic pathogen that

188 Klebsiella pneumoniae is an opportunistic pathogen which

189 Klebsiella pneumoniae is now recognized as an urgent thr

190 Klebsiella pneumoniae is part of the healthy human micro

191 Klebsiella pneumoniae is the most clinically relevant sp

192 esequencing of three plasmids in a reference Klebsiella pneumoniae isolate demonstrated approximately

193 Klebsiella pneumoniae isolated from screening swabs and

194 Escherichia coli, Pseudomonas aeruginosa, or Klebsiella pneumoniae) isolated from clinical cases.

195 re prepared at various dilutions using three Klebsiella pneumoniae isolates containing blaNDM.

196 and Etest against 48 clinical KPC-producing Klebsiella pneumoniae isolates for polymyxin B, tigecycl

197 0% of Escherichia coli isolates and 24.2% of Klebsiella pneumoniae isolates globally, with rates reac

198 Klebsiella pneumoniae isolates harboring the K. pneumoni

199 ically-related NDM-1 carbapenemase producing Klebsiella pneumoniae isolates identified during an outb

200 bsiella pneumoniae carbapenemase (KPC) in 47 Klebsiella pneumoniae isolates using a novel automated m

201 tamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated.

202 dated 2010 CLSI recommendations, to identify Klebsiella pneumoniae isolates with reduced susceptibili

203 richia coli isolates, 99.1% (109/110) of the Klebsiella pneumoniae isolates, and 95.8% (46/48) of the

204 prim-resistant clinical Escherichia coli and Klebsiella pneumoniae isolates, suggesting that they may

205 pneumoniae carbapenemase (KPC)-producing non-Klebsiella pneumoniae isolates.

206 Klebsiella pneumoniae K1 is a major agent of hepatic abs

207 A collection of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus m

208 428) and 9,371 isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus m

209 Two types of Klebsiella pneumoniae (KP) strains are currently emergin

210 The spread of Klebsiella pneumoniae (Kp) strains that produce K. pneum

211 Recently, in Klebsiella pneumoniae (Kp), PqqD and PqqE were shown to

212 sceptibility against carbapenemase-producing Klebsiella pneumoniae (KPC).

213 ture and activity of allantoin racemase from Klebsiella pneumoniae (KpHpxA).

214 ne domain of the Outer membrane protein A of Klebsiella pneumoniae (KpOmpA).

215 Escherichia coli PI-7, blaCTX-M-15-positive Klebsiella pneumoniae L7, and blaOXA-48-positive E. coli

216 hogens Burkholderia mallei, Yersinia pestis, Klebsiella pneumoniae, Legionella longbeachae, and Coxie

217 ei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneumoniae, Legionella pneumophila, Pseudomon

218 Here, we show the increased prevalence of Klebsiella pneumoniae lipopolysaccharide O2 serotype str

219 Klebsiella pneumoniae liver abscess (KPLA) is prevalent

220 Endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess is a blinding infect

221 ential of bacteriophages in a mouse model of Klebsiella pneumoniae lobar pneumonia.

222 ell types and the mechanisms associated with Klebsiella pneumoniae-mediated MCP-1-dependent neutrophi

223 Carbapenem-resistant Klebsiella pneumoniae, most notably isolates classified

224 ase genes were most frequently identified in Klebsiella pneumoniae (n = 1,127), Escherichia coli (n =

225 Klebsiella pneumoniae (n = 180, 41.9%), Escherichia coli

226 Monomicrobial Klebsiella pneumoniae NF (KP-NF) has been reported since

227 Here we present the structures of Klebsiella pneumoniae OHCU decarboxylase in unliganded f

228 1%) of 5332 E coli isolates, 13 (<1%) of 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter clo

229 formance data are available, results for all Klebsiella pneumoniae or Klebsiella oxytoca and E. coli

230 s, several compounds that block the UGM from Klebsiella pneumoniae or Mycobacterium tuberculosis were

231 dministration of pathogenic bacteria, either Klebsiella pneumoniae or Salmonella enterica serovar Typ

232 ilis epsHIJK locus into pga-deleted E. coli, Klebsiella pneumoniae, or alginate-negative Pseudomonas

233 ter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca that were r

234 (FMDV) veterinary outbreak in England and a Klebsiella pneumoniae outbreak in a Nepali neonatal unit

235 hese findings can help up better predict MDR Klebsiella pneumoniae outbreaks associated with specific

236 PS) of the multiresistant clinical strain of Klebsiella pneumoniae, PCM2713, and thus should be regar

237 radrenergic neurons improves survival during Klebsiella pneumoniae peritonitis (67 versus 23%, p < 0.

238 We used a model of Klebsiella pneumoniae pneumonia in wild-type mice and mi

239 Klebsiella pneumoniae poses a major challenge to healthc

240 Klebsiella pneumoniae primary liver abscess (KPLA) is an

241 y resistant isolates of Escherichia coli and Klebsiella pneumoniae (PRIMERS I).

242 used by gram-negative pathogens, among which Klebsiella pneumoniae prominently features.

243 chia coli/Shigella spp., Klebsiella oxytoca, Klebsiella pneumoniae, Proteus spp., Pseudomonas aerugin

244 Enterococcus faecium, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acine

245 pathogens including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Esche

246 f Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphyloc

247 e-dependent protection of mice from a lethal Klebsiella pneumoniae pulmonary challenge.

248 Klebsiella pneumoniae remains an important cause of intr

249 genesis of pyrroloquinoline quinone (PQQ) in Klebsiella pneumoniae requires the expression of six gen

250 lmonella typhimurium, Erwinia carotovora and Klebsiella pneumoniae rescue E. coli cells from stress d

251 at was not observed in the control organism (Klebsiella pneumoniae) research community.

252 Klebsiella pneumoniae resistance to third generation cep

253 substitution in the SHV beta-lactamase, from Klebsiella pneumoniae , results in resistance to ampicil

254 cid-metabolizing gene cluster and pathway of Klebsiella pneumoniae revealed two major open reading fr

255 low molecular weight bacteriocin produced by Klebsiella pneumoniae RYC492, has been shown to exist in

256 aa ribosomal antibiotic peptide produced by Klebsiella pneumoniae RYC492.

257 , Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonellae typhi, Candida albica

258 ed susceptibility to Escherichia coli K1 and Klebsiella pneumoniae sepsis in antibiotic-treated neona

259 Here, we investigate the process in Klebsiella pneumoniae serotype O12 (and Raoultella terri

260 ainst SP-A- and SP-B(N)-resistant capsulated Klebsiella pneumoniae (serotype K2) at neutral pH.

261 nts performed in germfree mice infected with Klebsiella pneumoniae showed that these animals are dras

262 on by Aggregatibacter actinomycetemcomitans, Klebsiella pneumoniae, Staphylococcus aureus, Staphyloco

263 previously unsequenced multi-drug resistant Klebsiella pneumoniae strain BAA-2146 (KpnNDM).

264 tance plasmid pJHCMW1, first identified in a Klebsiella pneumoniae strain isolated from a neonate wit

265 For the rich mobilome of a hospital Klebsiella pneumoniae strain, circularization junctions

266 Carbapenem-resistant Klebsiella pneumoniae strains classified as multilocus s

267 ence of mcr-1 was investigated in E coli and Klebsiella pneumoniae strains collected from five provin

268 Klebsiella pneumoniae strains deleted for pal or lppA ex

269 Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae

270 Since carbapenemase-producing Klebsiella pneumoniae strains were first reported in Nor

271 ded-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae strains.

272 wk and then challenged intratracheally with Klebsiella pneumoniae, Streptococcus pneumoniae, or lipo

273 ly related gram-negative pneumonic organism (Klebsiella pneumoniae) suggesting the inhibition may be

274 production induced by gram-negative bacteria Klebsiella pneumoniae, suggesting that monocytic TM play

275 ed as model pJHCMW1, a plasmid isolated from Klebsiella pneumoniae that includes two beta-lactamase a

276 o human pathogens, Staphylococcus aureus and Klebsiella pneumoniae, that utilize this metal nutrient

277 umonic sepsis using pulmonary infection with Klebsiella pneumoniae, the expression of MGL1 was upregu

278 In Klebsiella pneumoniae, the small basic connector protein

279 ing the sequence type 258 (ST258) lineage of Klebsiella pneumoniae There was very little evidence of

280 zontal gene transfer (HGT) of blaOXA-48 from Klebsiella pneumoniae to Escherichia coli in an infected

281 acheally inoculated with either live or dead Klebsiella pneumoniae to induce either lung infection or

282 -derived sepsis caused by the human pathogen Klebsiella pneumoniae to study the role of platelets in

283 d by uropathogenic Escherichia coli (UTI89), Klebsiella pneumoniae (TOP52 1721), and Enterococcus fae

284 , as well as in a model of lung infection by Klebsiella pneumoniae Transferring serum from Ig-deficie

285 cation of DNA from Staphylococcus aureus and Klebsiella pneumoniae, two pathogens commonly related to

286 ) mice with the common human sepsis pathogen Klebsiella pneumoniae via the airways to induce pneumoni

287 -type and C/EBPdelta(-/-) mice infected with Klebsiella pneumoniae via the airways.

288 teria could reduce bacterial burden in vivo, Klebsiella pneumoniae was injected into the tail veins o

289 Klebsiella pneumoniae was isolated from retail meats fro

290 T CRE infection was identified in 59 (15.7%) Klebsiella pneumoniae was isolated in 83.2%; surgical si

291 sphoenolpyruvate carboxylase gene (ppc) from Klebsiella pneumoniae was overexpressed to access the on

292 The HpxO enzyme from Klebsiella pneumoniae was recently proposed, on the basi

293 immunization with the encapsulated bacteria Klebsiella pneumoniae, we found that B cells, which larg

294 , bloodstream, and i.p. responses to LPS and Klebsiella pneumoniae were investigated using murine mod

295 ndogenous endophthalmitis is associated with Klebsiella pneumoniae whereas Coagulase negative Staphyl

296 Inactivation of the apbE gene in Klebsiella pneumoniae, wherein the nqr operon and apbE a

297 coccus faecalis, Pseudomonas aeruginosa, and Klebsiella pneumoniae, which are frequently implicated i

298 ct infections by the Gram-negative bacterium Klebsiella pneumoniae, which is a proficient biofilm for

299 subjected to intra-abdominal infection with Klebsiella pneumoniae, which results in liver injury and

300 During 2013, ST278 Klebsiella pneumoniae with blaNDM-7 was isolated from th